Vext Science, Inc. (VEXT.CN)
CAD 0.13
(4.0%)
CAD 0.13
(4.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 12.03 Million USD | 43.91% |
| 2022 | 13.81 Million USD | 45.81% |
| 2021 | 9.47 Million USD | 20.84% |
| 2020 | 7.84 Million USD | 20.94% |
| 2019 | 6.48 Million USD | 61.05% |
| 2018 | 4.02 Million CAD | 38.2% |
| 2017 | 2.91 Million CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 5.31 Million USD | 16.61% |
| 2024 Q1 | 4.57 Million USD | -73.94% |
| 2023 Q3 | 4.52 Million USD | 127.21% |
| 2023 Q2 | 1.99 Million USD | -48.75% |
| 2023 Q4 | 9.52 Million USD | 110.34% |
| 2023 Q1 | 3.88 Million USD | 14.34% |
| 2023 FY | 19.88 Million USD | 43.91% |
| 2022 Q2 | 3.33 Million USD | -12.71% |
| 2022 Q1 | 3.82 Million USD | 64.46% |
| 2022 FY | 13.81 Million USD | 45.81% |
| 2022 Q3 | 3.58 Million USD | 7.53% |
| 2022 Q4 | 3.4 Million USD | -5.18% |
| 2021 Q3 | 2.26 Million USD | 3.76% |
| 2021 Q2 | 2.18 Million USD | -19.12% |
| 2021 Q1 | 2.7 Million USD | 46.76% |
| 2021 FY | 9.47 Million USD | 20.84% |
| 2021 Q4 | 2.32 Million USD | 2.5% |
| 2020 FY | 7.84 Million USD | 20.94% |
| 2020 Q1 | 2.34 Million USD | 19.98% |
| 2020 Q4 | 1.84 Million USD | 4.0% |
| 2020 Q3 | 1.76 Million USD | -6.38% |
| 2020 Q2 | 1.89 Million USD | -19.24% |
| 2019 FY | 6.48 Million USD | 61.05% |
| 2019 Q2 | 1.73 Million USD | 52.28% |
| 2019 Q1 | 1.14 Million USD | 12.57% |
| 2019 Q4 | 1.95 Million USD | 18.2% |
| 2019 Q3 | 1.65 Million USD | -5.12% |
| 2018 Q2 | 966.74 Thousand USD | 1.97% |
| 2018 Q3 | 1.09 Million USD | 13.36% |
| 2018 Q4 | 1.01 Million USD | -7.4% |
| 2018 FY | 4.02 Million CAD | 38.2% |
| 2018 Q1 | 948.08 Thousand USD | 0.0% |
| 2017 FY | 2.91 Million CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Aion Therapeutic Inc. | 163.11 Thousand CAD | -7280.24% |
| Ayurcann Holdings Corp. | 11.71 Million CAD | -2.75% |
| Blueberries Medical Corp. | 84.22 Thousand CAD | -14193.174% |
| The BC Bud Corporation | 1.28 Million CAD | -838.316% |
| BioNxt Solutions Inc. | 6.73 Million CAD | -78.623% |
| CordovaCann Corp. | 3.86 Million CAD | -211.748% |
| Christina Lake Cannabis Corp. | 4.28 Million CAD | -181.064% |
| Captor Capital Corp. | 16.28 Million CAD | 26.065% |
| City View Green Holdings Inc. | 705.7 Thousand CAD | -1605.863% |
| 1CM Inc. | 7.3 Million CAD | -64.732% |
| Global Hemp Group Inc. | 551.7 Thousand CAD | -2082.029% |
| Greenway Greenhouse Cannabis Corporation | 4.8 Million CAD | -150.403% |
| IM Cannabis Corp. | 22.63 Million CAD | 46.822% |
| Lobe Sciences Ltd. | 4.13 Million CAD | -191.331% |
| Maple Leaf Green World Inc. | 392.21 Thousand CAD | -2969.336% |
| Mountain Valley MD Holdings Inc. | 60 Thousand CAD | -19964.043% |
| Nextleaf Solutions Ltd. | 1.76 Million CAD | -580.903% |
| Ovation Science Inc. | 54.1 Thousand CAD | -22152.174% |
| Pharmadrug Inc. | 1.33 Million CAD | -801.746% |
| Captiva Verde Wellness Corp. | 1.3 Million CAD | -822.197% |
| RAMM Pharma Corp. | 7.48 Million CAD | -60.933% |
| RIV Capital Inc. | 21.1 Million CAD | 42.952% |
| Revive Therapeutics Ltd. | 3.28 Million CAD | -266.387% |
| Red White & Bloom Brands Inc. | 37.75 Million CAD | 68.118% |
| SLANG Worldwide Inc. | 24.6 Million CAD | 51.075% |
| 1933 Industries Inc. | 5.12 Million CAD | -134.885% |
| Red Light Holland Corp. | 2.02 Million CAD | -495.824% |
| Top Strike Resources Corp. | 3.63 Million CAD | -231.477% |
| Xebra Brands Ltd. | -308.42 Thousand CAD | 4003.232% |
| Adastra Holdings Ltd. | 9.36 Million CAD | -28.608% |